Showing results (61-70 of 103) with videos related to
Sort By:
Pageof 11
The Clinical Respiratory Journal|March 12, 2025
Differences in Radiological and Pathological Findings by ANCA-Subtype in ANCA-Positive Idiopathic Interstitial PneumoniasTetsuro Sawata, Susumu Sakamoto, Yusuke Usui, et al.The Clinical Respiratory Journal|February 18, 2015
An exploratory trial of intravenous immunoglobulin therapy for idiopathic pulmonary fibrosis: a preliminary multicenter reportNoriyuki Enomoto, Kingo Chida, Takafumi Suda, et al.Heart and Vessels|March 16, 2022
Cardiac involvement in coronavirus disease 2019 assessed by cardiac magnetic resonance imaging: a meta-analysisShingo Kato, Mai Azuma, Kazuki Fukui, et al.Respiratory Investigation|December 7, 2021
Expectations of respiratory physicians from psychologists in palliative care for patients with non-cancer respiratory diseasesYoshinobu Matsuda, Takako Kosugi, Masako Yamanaka, et al.Plos One|August 27, 2016
Clinical Features of Idiopathic Interstitial Pneumonia with Systemic Sclerosis-Related Autoantibody in Comparison with Interstitial Pneumonia with Systemic SclerosisHideaki Yamakawa, Eri Hagiwara, Hideya Kitamura, et al.BMC Pulmonary Medicine|December 2, 2016
Long-term clinical course of anti-glycyl tRNA synthetase (anti-EJ) antibody-related interstitial lung disease pathologically proven by surgical lung biopsyHajime Sasano, Eri Hagiwara, Hideya Kitamura, et al.Scientific Reports|September 9, 2017
Low body surface area predicts hepatotoxicity of nintedanib in patients with idiopathic pulmonary fibrosisSatoshi Ikeda, Akimasa Sekine, Tomohisa Baba, et al.Medicine|June 6, 2022
Randomized phase II study of nintedanib with or without pirfenidone in patients with idiopathic pulmonary fibrosis who experienced disease progression during prior pirfenidone administrationSatoshi Ikeda, Akimasa Sekine, Tomohisa Baba, et al.Thoracic Cancer|July 15, 2022
Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapyAkimasa Sekine, Goushi Matama, Eri Hagiwara, et al.Respirology (Carlton, Vic.)|January 15, 2023
Nintedanib in Asian patients with progressive fibrosing interstitial lung diseases: Results from the INBUILD trialYoshikazu Inoue, Athol U Wells, Jin Woo Song, et al.Pageof 11